Enter your login e-mail to the account
Search
Search parameters
Search results
- ATRIAL FIBRILLATION IN GENERAL PRACTITIONER‘S PRACTICE AND VALUE OF RAAS INHIBITORS IN PREVENTION AND TREATMENT OF THIS ARRHYTHMIA
MUDr. Peter Jonáš, MUDr. Anton Farkaš
(12/2007, clearly ) - Pharmacological therapy of the heart failure
doc. MUDr. Peter Mitro, PhD.
(1/2009, Review articles ) - New possibilities in the pharmacotherapy of primary hypertension
MUDr. Viera Smetanová, PhD.
(2/2010, Review articles ) - Pharmacotherapy of rheumatoid arthritis II. – biological therapy
doc. MUDr. Želmíra Macejová, PhD., doc. MUDr. Ivan Rybár, PhD.
(2/2010, Drugs & drug classes ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - Overview of results in selected pharmacoeconomic studies with valsartan
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(11/2009, Pharmacoeconomics ) - Diabetes and obesity (diabesity) and COVID-19
doc. MUDr. Ľubomíra Fábryová, PhD., MPH
(4/2022, Topic of the year ) - Current perspective on treating erectile dysfunction in the general practitioner's surgery
MUDr. Pavel Turčan
(1/2016, Interdisciplinary consilium ) - PET a PET/CT v onkológii
MUDr. Andrej Vondrák, MUDr. Vladimír Vondrák
(9/2007, Consilium ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Pohled na otázky kardiovaskulárního rizika moderních nesteroidních antirevmatik
MUDr. David Suchý
(4/2004, Spectrum ) - Efficiency and safety of linagliptin – relevance to clinical practice
doc. MUDr. Martin Prázný, CSc., Ph.D., MUDr. Jan Šoupal
(2/2014, Review articles ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - Overview of results in selected in pharmacoeconomic study of ACEi ramipril
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(2/2009, Pharmacoeconomics ) - Správa zo XIV. slovenských obezitologických dní s medzinárodnou účasťou
MUC. Michal Pečík
(5/2016, Events ) - Anticoagulant therapy in patients with atrial fibrillation
Doc. MUDr. Ján Kmec, PhD., MPH
(2/2017, Review articles ) - CHRONIC HEART FAILURE AND DIABETES MELLITUS
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Topic ) - Artériová hypertenzia: klinické a výskumné trendy 2015. XIII. sympózium o artériovej hypertenzii v Prahe (Česká republika)
doc. MUDr. Marian Sninčák, CSc., mim. prof.
(3/2015, Events ) - PHARMACOTHERAPY OF ARTERIAL HYPERTENSION IN PATIENTS WITH CORONARY HEART DISEASE
PharmDr. Lívia Magulová, PhD., h. doc. MUDr. Jana Sirotiaková, PhD., MUDr. Peter Minárik
(4-5/2008, clearly ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - PSORIASIS – NEWS IN PATHOGENESIS AND THERAPY
MUDr. Zoltán Szép
(3/2005, Topic ) - INCRETINS, INCRETIN EFFECT AND DIABETES MELLITUS
MUDr. Adriana Ilavská
(S4/2007, Supplement ) - Pharmacotherapy of chronic forms of ischemic limb disease according to current guidelines
MUDr. Jiří Holý, MUDr. Martin Holý, MUDr. Zsolt Keczkemethy, MUDr. Kamila Nováková, MUDr. Pavel Havránek
(3/2012, Review articles ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - New possibilities of treatment of type 2 diabetes mellitus
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(3-4/2014, Review articles ) - Chronic myeloid leukemia – model of successful targeted therapy of oncologic disease
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD
(3-4/2014, Interdisciplinary consilium ) - NON-OPIOID ANALGETICS IN THE TREATMENT OF CHRONIC PAIN
MUDr. Igor Martuliak, PhD.
(6/2005, Topic ) - COXIBS IN RHEUMATOLOGY
doc. MUDr. Jozef Lukáč, CSc., prof. MUDr. Jozef Rovenský, DrSc., MUDr. Oľga Lukáčová, PhD.
(2/2005, Topic ) - POSITION OF ANGIOTENSIN 2-RECEPTOR BLOCKERS IN THE TREATMENTS OF ARTERIAL HYPERTENSION AND CURRENT MEDICINE
doc. MUDr. Marian Sninčák, PhD.
(1/2007, Topic ) - Fixed-dose combinations of calcium channel blockers and angiotensin-converting enzyme inhibitors in hypertension
MUDr. Slavomír Šuch
(3/2010, Drugs & drug classes ) - COVID-19, ibuprofén, inhibítory angiotenzín-konvertujúceho enzýmu, sartany
MUDr. Mgr. Jaroslav Hrenák, PhD., MUDr. Kristína Repová, PhD.
(2/2020, Information & comments ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - Metformin – current position in the treatment of type 2 diabetes mellitus and discussed questions of its using
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(4/2015, Review articles ) - Weight loss pharmacotherapy of obese non-diabetic and type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(6/2015, Topic of the year ) - Sitagliptine – representative of the new group of drugs indicated in the treatment of type 2 diabetes mellitus
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(4/2010, Drugs & drug classes ) - TREATMENT OF PATIENT WITH CONGESTIVE HEART FAILURE
prof. MUDr. Ján Murín, CSc.
(9/2006, Main topic ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - ARE THE PROBLEMS OF THE TREATMENT OF PEPTIC ULCER DISEASE 23 YEARS AFTER DISCOVERING HELICOBACTER PYLORI SOLVED?
MUDr. Rudolf Hrčka, CSc.
(10/2006, Main topic ) - Diabetes and heart failure
prof. MUDr. Ján Murín, CSc., doc. MUDr. Jozef Bulas, CSc.
(1/2014, Review articles ) - Medications, natural substances, and dietary supplements in treating sexual dysfunctions: a sexologist’s perspective
MUDr. Ondřej Trojan
(1/2017, Electronic attachment ) - Depressive disorders in general practitioners practice – part I.
MUDr. Peter Marko
(10/2009, General Medicine ) - Diabesity, an increasing medical problem – diabetologist must be therefore also an obesitologist
doc. MUDr. Boris Krahulec, CSc., MUDr. Daša Mesárošová, PhD.
(4/2016, Topic of the year ) - Triple therapy with protease inhibitors – new standard of care in chronic hepatitis C treatment
doc. MUDr. Pavol Kristian, PhD., prof. MUDr. Ivan Schréter, CSc., doc. MUDr. Peter Jarčuška, PhD.
(6/2011, Review articles ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - Benign prostatic hyperplasia, diagnostics and contemporary opportunities of miniinvasive treatment
MUDr. Jiří Klečka, Ph.D., MUDr. Petr Běhounek, doc. MUDr. Milan Hora, Ph.D., MUDr. Viktor Eret
(1/2011, Interdisciplinary consilium ) - OPTIMAL (TARGET) DOSING OF ACE INHIBITORS
doc. MUDr. Jana Sirotiaková, PhD., PhD., Peter Minárik
(12/2008, clearly )
- Recommendations for the treatment of unipolar depressive disorder
MUDr. Ľubica Forgáčová, PhD.
(4/2010, Recommendations for practice ) - Vortioxetine – the antidepressant with multimodal activity
doc. MUDr. Ján Pečeňák, CSc.
(1/2015, Psychopharmacology ) - Tobacco smoking and depression
MUDr. Michal Turček, PhD.
(2/2013, Review articles ) - Interactions of tobacco smoke with psychotropic medications
MUDr. Michal Turček, PhD.
(4/2011, Review articles ) - Current trends in the cognitive pharmacotherapy of Alzheimer´s disease
MUDr. Roman Jirák, CSc.
(2/2002, Review articles ) - Demention with Lewy’s Bodies, Diagnosis, Clinical Meaning, Treatment
MUDr. Jiří Konrád
(1/2004, Review articles ) - PHARMACOTHERAPY OF DEMENTIA
doc. MUDr. Vladimír Pidrman, Ph.D.
(5/2007, Review articles ) - Nové trendy v léčbě obsedantně kompulzivní poruchy
MUDr. Pavla Stopková, Ph.D.
(2/2018, Review articles ) - Treatment discontinuation in anxiety and depressive disorders
MUDr. Jiřina Kosová
(2/2004, Review articles ) - Dysthymia and its therapy
MUDr. Ján Praško, CSc. , MUDr. Erik Herman, doc. MUDr. Jiří Hovorka, CSc.
(6/2002, Review articles ) - Výzkum nových léčiv u Alzheimerovy choroby
PharmDr. Jana Hroudová, Ph.D.
(2/2018, Review articles ) - Sexual dysfunctions and longterm antidepressants intaken
MUDr. Luboš Janů, Ph.D.
(1/2001, Review articles ) - Long-term use of cognitive drugs in Alzheimer disease
MUDr. Vanda Franková
(4/2004, Review articles ) - Optimising treatment in Alzheimer’s disease
MUDr. Vanda Franková
(4/2016, Review articles ) - Combined therapy by Alzheimer´s disease
MUDr. Elena Žigová
(1/2013, Original articles & case reports ) - THE USE OF DUAL ANTIDEPRESSANTS IN THE TREATMENT OF DEPRESSIVE DISORDER
MUDr. Luboš Janů, Ph.D. , MUDr. Sylva Racková
(6/2008, Review articles ) - SSRI IN THE SPECTRUM OF ANXIETY DISORDERS
doc. MUDr. Vladimír Pidrman, Ph.D.
(1/2003, Review articles ) - Interdisciplinary approach in dementia treatment by cholinesterase inhibitors
doc. MUDr. Vladimír Pidrman, Ph.D., MUDr. Klára Látalová, doc. MUDr. Jiří Horáček, CSc.
(3/2003, Review articles ) - Antidepressant – indued sexual dysfunction
MUDr. Michal Maršálek, CSc.
(3/2003, Review articles ) - THERAPEUTICAL APPROACHES IN BEHAVIORAL DISORDERS IN DEMENTIA
MUDr. Vanda Franková
(6/2007, Review articles ) - CURRENT TRENDS IN THE BIOLOGICAL TREATMENT OF ALZHEIMER DISEASE
MUDr. Roman Jirák, CSc.
(1/2006, Review articles ) - THE TREATMENT OF PSYCHOTIC DEPRESSION – ACUTE AND CONTINUATION DRUG TREATMENT
MUDr. Martin Bareš, MUDr. Miloslav Kopeček
(1/2006, Review articles ) - Venlafaxin s prodlouženým uvolňováním v ambulantní praxi
MUDr. Luboš Janů, Ph.D.
(1/2006, Outpatient psychiatry ) - TREATMENT OF DEPRESSION WITH ANXIETY AND INSOMNIA
MUDr. Jiřina Kosová
(1/2007, Review articles ) - BEHAVIORAL DISTURBANCES IN DEMENTIA
MUDr. Martin Brunovský, Ph.D.
(2/2006, Review articles ) - PHARMACOTHERAPEUTIC OPTIONS IN DEPRESSION
prof. MUDr. Eva Češková, CSc.
(5/2005, Review articles ) - NEW TREATMENT POSSIBILITIES FOR BIPOLAR DEPRESSION
prof. MUDr. Eva Češková, CSc.
(3/2006, Review articles ) - Psychosomatic and psychosocial issues of cardiovascular diseases
prof. MUDr. Jaroslav Šimon, DrSc.
(1/2004, Review articles ) - ATYPICAL ANTIPSYCHOTICS IN TREATMENT RESISTANT DEPRESSION
MUDr. Dagmar Seifertová, CSc., MUDr. Martin Bareš, Ph.D., MUDr. Milan Kopeček
(3/2006, Review articles ) - DEPRESSION, CORONARY ARTERY DISEASE, AND MYOCARDIAL INFARCTION
MUDr. Jiří Podlipný, MUDr. Zdeněk Hess
(4/2006, Review articles ) - A surprising effect of memantine on the progression of Alzheimer‘s disease
MUDr. Jan Kolouch, CSc., MUDr. František Koukolík, DrSc., MUDr. Barbora Balíková
(4/2010, Original articles & case reports )
- New in pharmacotherapy of dementia
MUDr. Martin Vališ, Ph.D., MUDr. Dita Kalnická
(1/2011, Review articles ) - Účinnost a snášenlivost galantaminu v léčbě Alzheimerovy nemoci
doc. MUDr. Vladimír Pidrman, Ph.D., MUDr. Klára Látalová, , RNDr. Ing. Karel Chroust, Ph.D.
(5/2006, Review articles ) - Treatment of Parkinson’s disease
prof. MUDr. Ivan Rektor, CSc.
(6/2009, Main topic ) - INHIBITORY CHOLINESTERÁZ V LÉČBĚ ALZHEIMEROVY NEMOCI
MUDr. Martin Brunovský, Ph.D.
(2/2007, Review articles ) - Neurological complications of cancer immunotherapy
prof. MUDr. Ivana Štětkářová, CSc., MHA, FEAN
(5/2023, Main topic ) - Deprese u neurologických onemocnění: výskyt a její léčba
MUDr. Sylva Racková
(3/2018, From the boundary of neurology ) - Effects of drugs on neuromuscular junction
MUDr. Stanislav Voháňka, CSc., MBA
(1/2017, Main topic ) - Alzheimer’s disease and mild cognitive impairment: diagnosis and treatment
MUDr. David Doležil, Ph.D. , RNDr. Daniela Řípová, CSc., doc. MUDr. Aleš Bartoš, Ph.D., MUDr. Linda Čechová
(3/2011, Review articles ) - Chemotherapy-induced polyneuropathy
MUDr. Jana Raputová, MUDr. Eva Vlčková, Ph.D., MUDr. Lenka Šmardová, MUDr. Aneta Rajdová, doc. MUDr. Andrea Janíková, Ph.D.
(1/2017, Main topic )
- CURRENT VIEW ON THE PATHOGENESIS AND MANAGEMENT OF ATOPIC DERMATITIS
MUDr. Dušan Buchvald Ph.D.
(2/2005, Review articles ) - INFLUENZA IN CHILDREN
MUDr. Zuzana Blechová
(6/2007, Review articles ) - Topical immunomodulators in the treatment of atopic dermatitis
prof. MUDr. Jagienka Jautová, PhD., MBA, MUDr. Janette Baloghová, PhD.
(3/2009, Drugs & drug classes ) - Atopic dermatitis – what´s new?
Doc. MUDr. Růžena Pánková, CSc.
(5/2015, Review articles )
- The actual pharmacotherapy benign hyperplasia according to EAU Guidelines
MUDr. Aleš Horák
(3/2021, Review articles ) - Renal carcinoma and immunotherapy
MUDr. Alexandr Poprach, Ph.D., MUDr. Radek Lakomy, Ph.D.
(2/2017, Review articles ) - PARP inhibitors in treating metastatic castration-resistant prostate cancer
MUDr. Igor Richter, Ph.D., doc. MUDr. Josef Dvořák, Ph.D., MUDr. Vladimír Šámal, Ph.D., MUDr. Jiří Bartoš, MBA, MUDr. Sofya Al-Samsam
(3/2023, Review articles ) - Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology ) - ERECTILE DYSFUNCTION – NEW PREFERENCES IN TREATMENT?
MUDr. Libor Zámečník, FEBU
(1/2008, Review articles ) - Drug interactions in urology – what to watch out for
PharmDr. Josef Suchopár, MUDr. Michal Prokeš, Štěpán Suchopár
(2/2020, Drug interaction ) - Drug interactions of medications used in the therapy of erectile dysfunction with dietary supplements
PharmDr. Josef Suchopár, Mgr. Štěpán Suchopár, MUDr. Michal Prokeš
(2/2023, Drug interaction )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - Management of pacients with CML resistant or intolerant to tyrosine kinase inhibitor – imatinib
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Juraj Halička, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD.
(4/2012, Topic of the year ) - Primary myelofibrosis – current view of pathophysiology, prognosis and treatment
Prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2018, Spectrum ) - Treatment of EGFR- mutated non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(1/2021, Main topic ) - Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors
doc. MUDr. Peter Beržinec, CSc.
(6/2014, Information & comments ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Current treatment options for BRAF mutant metastatic colorectal cancer
MUDr. Radovan Barila, PhD., MUDr. Igor Andrašina, CSc.
(1/2022, Main topic ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - Chronic lymphocytic leukemia - how to treat a patient with relapsed or refractory disease in the era of signaling pathway inhibitors
MUDr. Firas Farkaš, PhD.
(1/2022, Case reports ) - Impact of CDK 4/6 inhibitors on overall survival of patients with advanced breast cancer – in the light of new data
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2024, Company information ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Current recommendations for bisphosphonates therapy in cancer patients
prof. MUDr. Stanislav Špánik, CSc., MUDr. Beata Špániková, PhD.
(6/2013, Review articles ) - An update in breast cancer treatment
MUDr. Markéta Palácová
(4/2007, Review articles ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - Management of adverse reactions in treatment with mTOR and CDK4/6 inhibitors
MUDr. Branislav Bystrický, PhD., MPH
(2/2019, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - News in the immunotherapy of nonmetastatic non-small-cell lung cancer
MUDr. Lenka Medvecová
(1/2023, Main topic ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Myelofibrosis – diagnosis, management, new treatment options
MUDr. Anna Vallová
(6/2015, Review articles ) - Diagnosis of chronic myeloid leukemia
MUDr. Ľudmila Demitrovičová, MUDr. Lucia Copáková, MUDr. Eva Mikušková, Mgr. Michaela Leitnerová
(2/2012, Topic of the year ) - Current opinions on chemotherapy for prostate cancer
doc. MUDr. Ján Ľupták, PhD.
(3/2011, Review articles ) - Poly (ADP-ribose) polymerase inhibitors in the treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(5/2017, Review articles ) - Checkpoint inhibitors in treatment of malignant lymphoma
MUDr. Barbora Kašperová
(3/2019, Review articles ) - Immunotherapy and targeted treatment for metastatic, castration-resistant prostate cancer
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2022, Main topic ) - Immunotherapy in prostate cancer
MUDr. Katarína Rejleková, PhD.
(5/2020, Review articles ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Position of 4/6 cyclin-dependent kinase inhibitors in the 1st line of treatment of metastatic breast cancer
MUDr. Katarína Krajcsovics, PhD.
(4/2019, Review articles ) - Myelofibróza – posúdenie nových liečebných možností
MUDr. Antónia Hatalová
(5/2012, Editorial ) - Place of bosutinib in the therapy of chronic myeloid leukemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Angelika Bátorová, PhD.
(3/2016, Drugs & drug classes ) - Treatment of patients with metastatic renal cancer after treatment with tyrosine kinase inhibitors
MUDr. Mária Rečková, PhD.
(4/2019, Review articles ) - Systemic therapy of metastatic melanoma
MUDr. Tomáš Šálek
(6/2021, Review articles ) - WALDENSTRÖM‘S MACROGLOBULINEMIA – EPIDEMIOLOGY, ETHIOPATOGENESIS, DIAGNOSTIC AND TREATMENT
prof. MUDr. Elena Tóthová, CSc.
(5/2008, Review articles ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Treatment of metastatic clear cell renal cell carcinoma after failure of first-line treatment
MUDr. Marián Streško, PhD.
(4/2014, Main topic ) - HIF inhibitors and glutaminase inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Zuzana Tomčová
(3/2024, Main topic ) - ELN recommendations for management of CML patients 2013
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD.
(4/2014, Review articles ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Optimal first line treatment in advanced/metastatic renal carcinoma-immunotherapy, targeted therapy, combinations
MUDr. Katarína Rejleková, PhD.
(6/2020, Review articles ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Thyroid cancer
MUDr. Jana Ďurková
(1/2015, Review articles ) - Postavenie inhíbitorov aromatázy v adjuvantnej liečbe potmenopauzálnych žien s hormonálne pozitívnym karcinómom prsníka
MUDr. Jana Obertová
(2/2009, Review articles ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - How do we look at CDK4/6 inhibitors in palliative treatment today
MUDr. Miroslava Malejčíková
(2/2022, Main topic ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Advances in the treatment of triple- negative breast cancer
MUDr. Lea Balážová, doc. MUDr. Igor Andrašina, CSc.
(5/2022, Review articles ) - Skin toxicity of EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(6/2016, Review articles ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Chronic myeloid leukemia and its treatment in patients with repeated intolerance of tyrosine kinase inhibitors
MUDr. Radoslav Greksák, PhD.
(2/2020, Case reports ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - CHEMOPREVENTION OF BREAST CANCER
prof. MUDr. Ľudovít M. Jurga, DrSc., prof. MUDr. Myrón Malý, CSc.
(5/2007, Review articles ) - Decision-making algorithm in the therapy of patients with advanced malignant melanoma
MUDr. Silvia Jurišová, PhD.
(1/2024, Review articles ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - New trends in diagnosis and treatment of essential thrombocythemia and myelofibrosis
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2012, Review articles ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - The role of PARP inhibitors in the treatment of ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(4/2021, Main topic ) - Updated ESMO recommendations for the treatment of newly diagnosed ovarian epithelial carcinoma
doc. MUDr. Lýdia Heľpianska, CSc.
(3/2022, Review articles ) - Management of chronic myeloid leukemia after failure of second generation tyrosine kinase inhibitors
MUDr. Katarína Slezáková, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Peter Rohoň, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2022, Review articles ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - News in systemic treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(6/2018, Review articles ) - Principles of hormonal therapy and chemotherapy in the treatment of metastatic HR+, HER2- breast cancer
MUDr. Miroslava Malejčíková
(6/2018, Review articles ) - Management of skin toxicities associated with epidermal growth factor inhibitor cetuximab in combination with chemotherapy or radiotherapy
MUDr. Katarína Poláková
(6/2011, Review articles )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - Cardiovascular diseases and psoriasis
MUDr. Zuzana Baranová, PhD.
(3/2016, Review articles ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year ) - Tacrolimus in treatment of atopic dermatitis
MUDr. Janette Baloghová, PhD., prof. MUDr. Jagienka Jautová, PhD.
(3/2011, Drugs & drug classes ) - Subacute cutaneous lupus erythematodes in a patient with SHARP syndrome – case report
MUDr. Barbora Gulánová, MUDr. Martina Part, PhD., prof. MUDr. Mária Šimaljaková, PhD, MHA
(2/2017, Original articles & case reports ) - BIOLOGICA TREATMENT OF PSORIATIC ARTHRITIS
MUDr. Liliana Šedová, MUDr. Jiří Štolfa
(2/2007, Interdisciplinary overviews ) - Atopic dermatitis – what´s new?
Doc. MUDr. Růžena Pánková, CSc.
(1/2015, Review articles ) - Advers skin effect of target therapy in oncology
MUDr. Katarína Poláková, PhD.
(4/2018, Review articles ) - Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles ) - Upadacitinib in the treatment of atopic dermatitis
MUDr. Karolína Vorčáková, PhD.
(2/2023, Drugs and drug groups )
- POSITION OF ANGIOTENSIN 2-RECEPTOR BLOCKERS IN THE TREATMENTS OF ARTERIAL HYPERTENSION AND CURRENT MEDICINE
doc. MUDr. Marian Sninčák, PhD.
(3-4/2007, clearly ) - EFFECTIVITY AND SAFETY OF COXIBS
doc. MUDr. Jozef Lukáč, CSc., MUDr. Oľga Lukáčová, CSc.
(3-4/2007, clearly ) - OBSESSIVE-COMPULSIVE DISORDER
MUDr. Branislav Moťovský
(3/2008, Review articles ) - DIAGNOSTICS AND TREATMENT OF DEPRESSION IN DIABETES MELLITUS
MUDr. Ľubica Forgáčová, PhD.
(3/2008, Review articles ) - COMBINATION THERAPY FOR HYPERTENSION
Doc. MUDr. Milan Grundmann, CSc., MUDr. Ivana Kacířová
(2/2007, clearly ) - ACE – INHIBITORS AND AT1R – ANTAGONISTS ARE THE FIRST LINE MEDICATION FOR IgA NEPHROPATHY
prof. MUDr. Karel Matoušovic, DrSc.
(2/2008, Drug classes )
- Current opinions on the treatment of glaucoma
prof. MUDr. Gabriela Nosáľová, DrSc., doc. RNDr. Soňa Fraňová, PhD., MUDr. Peter Žiak, PhD., MUDr. Milena Čipkalová, doc. MUDr. Juraj Mokrý, PhD.
(4/2012, Current pharmacotherapy ) - Optimising treatment in Alzheimer’s disease
MUDr. Vanda Franková
(3/2016, Current pharmacotherapy ) - Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - Current possibilities of benign prostatic hyperplasia therapy part I.
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(3/2012, Current pharmacotherapy ) - The 42nd Days of Pharmacy with main topic „Diabetes“ – epidemic of the third millennium
doc. RNDr. Magdaléna Fulmeková, CSc.
(2/2016, Events ) - Rilmenidine use in clinical practice
MUDr. Martin Čaprnda, PhD.
(1/2014, Clinical pharmacy ) - Sitagliptin
Ondřej Krystyník
(1/2011, New medicinal substances ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Huperzine A and other natural substances in treating Alzheimer's disease
PharmDr. Jan Martin, Mgr. Zuzana Kršková, doc. RNDr. Jaroslav Dušek, CSc.
(2/2011, Phytotherapy ) - Current trends in treatment of atopic dermatitis – a minimum for pharmacists
MUDr. Petra Brodská, Ph.D.
(3/2023, Current pharmacotherapy )
- Current status and perspectives of pharmacotherapy of pulmonary arterial hypertension
MUDr. Pavel Jansa
(3/2011, Review articles ) - Inhibitors of factors XI and XII
doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. František Nehaj, PhD., MBA, MUDr. Juraj Chudej, PhD., MBA, MUDr. Lenka Lisá, PhD., MUDr. Ľudmila Lineková, MUDr. Ivan Kecskés, MBA, Prof. MUDr. Ján Staško, PhD.
(1/2024, Review articles ) - Hemophilia A and risk of inhibitor development – what changed the SIPPET study?
Prof. MUDr. Ján Staško, PhD., MUDr. Juraj Sokol, PhD., MUDr. Lucia Stančiaková, PhD., MUDr. Tomáš Šimurda, MUDr. Pavol Hollý, PhD, prof. MUDr. Peter Kubisz, DrSc.
(3-4/2017, Main topic ) - Acquired hemophilia A
Doc. MUDr. Mária Hulíková, PhD.
(3-4/2017, Main topic )
- The role and importance of measuring fibrinolytic agents uPA and PAI-1 in oncosurgical patients
MUDr. Soňa Huľová, MUDr. Edward Huľo, MUDr. Lucia Rišková, doc. MUDr. Jana Kaťuchová, PhD.
(2-3/2017, Review articles )